| Cutaneous T-Cell Lymphoma |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| CAR-T |
0 |
0.98 |
| Skin Cancer |
0 |
0.44 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.32 |
| Cancer |
0 |
0.29 |
| Lymphoma |
0 |
0.29 |
| Genomic Medicine |
0 |
0.23 |
| B-Cell Lymphoma |
0 |
0.22 |
| Peripheral T-cell Lymphoma |
0 |
0.22 |
| Immunotherapy |
0 |
0.99 |
| Multiple Myeloma |
0 |
0.07 |
| Pennsylvania |
0 |
0.07 |
| Quality of Life |
0 |
0.07 |